• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
    • Editorial Board
    • Contact
  • Issues
    • Current Issue
    • Issue Archives
  • Multimedia
  • Editor's Update
  • Advertise
  • Reprints
  • Authors & Reviewers
    • Author Instructions
    • Submission Portal
    • Reviewers

Search

TPA Works Well When Administered in the Clot

  • Thu, 6/7/12 - 10:14am
  • 1587 reads
  • 0 comments

A 43-year-old female presented with a 2 cm x 3 cm non-healing ulcer for 3 months on the dorsal of her foot. She was sent over from the wound care clinic. She was a non-smoker, non-diabetic woman with anorexia nervosa and protein C deficiency.

The patient’s primary care internist referred her to a vascular surgeon a month ago. He couldn’t cross her CTO and infused TPA x 52 H and still couldn't cross it. He told her to exercise and encouraged her to come back if her claudication worsened. The wound still did not heal and she continued to have resting claudication.

Figure 1. The angiogram was performed using the contralateral approach. Notice there is an occlusion just after 2 large collateral branches.

 

 

 

Figure 2. The popliteal vessel was not well seen.

 

 

 

 

Figure 3. Infrapopliteal vessels were sparse.

 

 

 

 

Figure 4. A 5 Fr Wildcat (Avinger) somewhat easily crossed the total occlusion.

 

 

 

Figure 5. Although it was easy to cross the CTO at the popliteal site while passing the Wildcat, it became hung up. We could not either advance it or retract it. Finally, with a fair amount of force on the Wildcat and 6 Fr contralateral sheath, we were able to remove the catheter.

 

 

Figure 6. When I pulled the catheter back, the angiogram showed that we had adequately recanalized the CTO. So, in spite of this clear dissection, we proceeded and crossed carefully passed the original occlusion with a .014 Whisper wire (Abbott Vascular).

 

 

Figure 7. After balloon dilation (AngioScore), there was complete resolution of the total occlusion with excellent 2-vessel run off and complete resolution of the dissection.

 

 

 

Conclusion

Within a week of recanalization of her CTO, there has already been an improvement in healing of the lesion. If you look at Figure 1, I suspect the vascular surgeon never delivered any TPA to the total occlusion and the drug was simply infused in the collateral branches. Utilizing the Wildcat, even resistant and recalcitrant CTOs have been able to cross fairly easily. Clearly, however, the stiff probe became embedded into calcific plaque. Luckily, we were able to remove the probe without any significant permanent arterial trauma.

Coauthors: Richard R. Heuser, MD, FACC, FACP, FESC, FSCAI and Timothy J. Kieborz, DO

Bookmark/Search this post with
  • Digg
  • LinkedIn
  • Reddit
  • Facebook Like
  • Google Plus One
  • Linkedin Share Button
  • Tweet Widget
Find more blogs image description image description
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. HMP Communications is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. HMP Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.


Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.
  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Kimberly Sutkowski, Classified Sales Representative
    (800) 237-7285, ext. 205

Vascular Access: The VDM Clinician Blog

Anticoagulant Treatment of DVT and Preventing DVT-PE Made Easier

Frank J Criado MD FACS FSVM

Retrograde Crossing: When the Front Door Is Locked, Look for Another Way In!

Ajay U. Mhatre MD

Collecting More Data for Vascular Patients

Lawrence A. Garcia MD

A Road Less Traveled: Access in the Right Brachial Artery

Ajay U. Mhatre MD

Endovascular Options for Complex Abdominal Aortic Aneurysms

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Elixir Medical Receives CE Mark Approval for the Fully Bioresorbable DESolve Novolimus Eluting Coronary Scaffold System
    Wed, 05/15/13 - 10:12am
  • Reverse Medical Corporation Announces CE Mark and Initial Clinical Experience with the MVP Micro Vascular Plug for Peripheral Embolization
    Wed, 05/15/13 - 8:55am
  • St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN System
    Wed, 05/15/13 - 8:52am
  • Decades of Improving Cholesterol Levels Abruptly Ended in 2008, PLOS ONE Study Finds
    Tue, 05/14/13 - 10:02am
more »

Clinical Events Calendar

  • EuroPCR 2013
    Tue, 05/21/2013 - Fri, 05/24/2013
    Paris, France
  • European Society for Vascular Surgery European Vascular Trauma Workshop
    Mon, 05/27/2013 - Tue, 05/28/2013
    Sweden
  • Society for Vascular Surgery Vascular Annual Meeting 2013 (SVS)
    Thu, 05/30/2013 - Sat, 06/01/2013
    San Francisco, CA, United States
more »

Poll

Drug-eluting balloons will have a major role in lower-extremity revascularization in the future.:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2013 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2013 HMP Communications